Way Towards New Life

Breast Cancer Medications

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Obtain access to an anti-breast cancer medication (an unapproved drug in India) for personal use.

Here is a list of some of the Anti-Cancer Drugs for Breast Cancer for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection

Indicated for the treatment of several types of cancer – HER2+ Metalistic Breast Cancer, HER2+ Low Metalistic Breast Cancer, HER2+ Advanced Breast Cancer,HER2+ Metalistic Lung Cancer..

KISQALI (ribociclib) tablets

Indicated for the treatment of advanced-stage or metastatic hormone-receptor-positive, HER2-negative breast cancer

TUKYSA (tucatinib) tablets

Indicated for the treatment of adults with: • human epidermal growth factor receptor-2 (HER2) positive breast cancer

ORSERDU (elacestrant) tablets

Indicated for the treatment of women who have gone through menopause and adult men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated advanced breast cancer

TRODELVY (sacituzumab govitecan-hziy) for injection

Indicated for the treatment of adults with: • a type of breast cancer that is estrogen and progesterone hormone receptor (HR) negative, and human epidermal growth factor receptor 2 (HER2)-negative

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Access Unauthorized Medicines In India Under NPP.

What is Named-patient access programme (NPP)?

Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).

These may be medicines that are:

  • Authorised but not yet available to be prescribed in the patient’s country.
  • Authorised and available in one country but not authorised and available in the patient’s country.
  • Discontinued in the patient’s country but not in another country.
  • In shortage in the patient’s country but not in another country.

Antibiotic

Arthritis

Diabetes

Genetics

Disorders

Hepatitis C

Hematologic Cancers

HIV/AIDS

Immunological Disorders

Liver Disease

Multiple Sclerosis

Nerver Disease

Oncology

Parkinson's Disease

Rare Disease

Soft Tissue Sarcoma

Transplant

Specialty Drugs

Get access to an imported medicines (unapproved drug in India) for breast cancer.

For personal use, get access to an imported medicines (unapproved drug in India) for breast cancer. On request, Anti-cancer medicines can be imported to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.